AI assistant
Sending…
Ryerson Holding Corp — Director's Dealing 2021
Apr 2, 2021
32490_dirs_2021-04-02_61b9eb40-60e8-460f-ae36-5119f38e12e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ryerson Holding Corp (RYI)
CIK: 0001481582
Period of Report: 2021-03-31
Reporting Person: Kannan Molly D (CAO & Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | Common Stock (par value $0.01 per share) | M | 825 | — | Acquired | 13810 | Direct |
| 2021-03-31 | Common Stock (par value $0.01 per share) | M | 825 | — | Acquired | 14635 | Direct |
| 2021-03-31 | Common Stock (par value $0.01 per share) | M | 1100 | — | Acquired | 15735 | Direct |
| 2021-03-31 | Common Stock (par value $0.01 per share) | M | 5025 | — | Acquired | 20760 | Direct |
| 2021-03-31 | Common Stock (par value $0.01 per share) | S | 2177 | $16.23 | Disposed | 18583 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | Restricted Stock Units | $ | M | 825 | Disposed | Common Stock (825) | Direct | |
| 2021-03-31 | Restricted Stock Units | $ | M | 825 | Disposed | Common Stock (825) | Direct | |
| 2021-03-31 | Restricted Stock Units | $ | M | 1100 | Disposed | Common Stock (1100) | Direct | |
| 2021-03-31 | Restricted Stock Units | $ | A | 4950 | Acquired | Common Stock (4950) | Direct | |
| 2021-03-31 | Stock Options | $16.5 | A | 7500 | Acquired | Common Stock (7500) | Direct |
Footnotes
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
F7: See Exhibit 99.1
F8: See Exhibit 99.1
F9: See Exhibit 99.1
F10: See Exhibit 99.1
F11: See Exhibit 99.1
More from Ryerson Holding Corp
Investor Presentation
2026
May 27
Regulatory Filings
2026
May 22
Proxy Solicitation & Information Statement
2026
Mar 18
Proxy Solicitation & Information Statement
2026
Mar 18
Director's Dealing
2026
Mar 2
Investor Presentation
2026
Feb 23
Annual Report
2026
Feb 23
Earnings Release
2026
Feb 19
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 13